Two Sigma Investments’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.59M | Buy |
189,412
+172,124
| +996% | +$2.36M | ﹤0.01% | 1615 |
|
|
2025
Q1 | $191K | Sell |
17,288
-39,607
| -70% | -$438K | ﹤0.01% | 2802 |
|
|
2024
Q4 | $606K | Sell |
56,895
-30,139
| -35% | -$321K | ﹤0.01% | 2384 |
|
|
2024
Q3 | $1.11M | Sell |
87,034
-13,388
| -13% | -$170K | ﹤0.01% | 2006 |
|
|
2024
Q2 | $1.69M | Buy |
100,422
+19,925
| +25% | +$334K | ﹤0.01% | 1592 |
|
|
2024
Q1 | $1.21M | Sell |
80,497
-50,258
| -38% | -$754K | ﹤0.01% | 1773 |
|
|
2023
Q4 | $1.96M | Buy |
130,755
+10,541
| +9% | +$158K | ﹤0.01% | 1497 |
|
|
2023
Q3 | $1.68M | Buy |
120,214
+100,399
| +507% | +$1.41M | ﹤0.01% | 1466 |
|
|
2023
Q2 | $205K | Buy |
+19,815
| New | +$205K | ﹤0.01% | 2557 |
|
|
2021
Q2 | – | Sell |
-19,800
| Closed | -$386K | – | 2913 |
|
|
2021
Q1 | $386K | Buy |
+19,800
| New | +$386K | ﹤0.01% | 1970 |
|
|
2018
Q4 | – | Sell |
-5,954
| Closed | -$281K | – | 2449 |
|
|
2018
Q3 | $281K | Sell |
5,954
-9,022
| -60% | -$426K | ﹤0.01% | 1768 |
|
|
2018
Q2 | $745K | Buy |
+14,976
| New | +$745K | ﹤0.01% | 1487 |
|
|
2018
Q1 | – | Sell |
-7,436
| Closed | -$277K | – | 2363 |
|
|
2017
Q4 | $277K | Buy |
+7,436
| New | +$277K | ﹤0.01% | 1955 |
|